Related Experiment Video
Updated: Jun 13, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Gut Microbiome Compositional and Functional Features Associate with Alzheimer's Disease Pathology
Jea Woo Kang1, Lora A Khatib2,3, Margo B Heston1
1Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA Address: 600 Highland Ave, J5/1 Mezzanine, Madison, WI, USA 53792.
Alzheimer's disease (AD) is linked to changes in the gut microbiome. This study found differences in gut microbes between AD patients and healthy individuals, associating these microbes with AD biomarkers.
Area of Science:
- Microbiome research
- Neurodegenerative disease
- Alzheimer's disease pathology
Background:
- The gut microbiome's role in Alzheimer's disease (AD) is increasingly recognized but not fully understood.
- Limited knowledge exists regarding specific microbial compositions and functions associated with AD pathology.
Purpose of the Study:
- To investigate the gut microbiome's composition and function in individuals with Alzheimer's disease.
- To identify associations between gut microbial features and established biomarkers of AD and related pathologies.
Main Methods:
- Shallow-shotgun metagenomic sequencing of fecal samples from the Wisconsin Microbiome in Alzheimer's Risk Study.
- Analysis of differential abundance and regression to link gut microbiome features with cerebrospinal fluid (CSF) biomarkers.
Main Results:
- Significant differences in gut microbiome composition and function were observed between AD patients and cognitively unimpaired individuals.
- These compositional differences were validated in an independent cohort.
- Specific gut microbial features were found to be significantly associated with CSF biomarkers of AD and related pathologies.
Conclusions:
- Gut microbial alterations are evident in Alzheimer's disease.
- The gut microbiome and its metabolic pathways are demonstrably linked to the pathological processes of AD.
More Related Videos
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment